About RainDance
RainDance is a Healthcare company based in Billerica (United States) founded in 2004, and was acquired by Bio Rad in January 2017. Developer of nucleic acid detection and quantification systems. It operates in the Healthcare and Technology sectors. RainDance has raised $111.66 million across 17 funding rounds from investors including Myriad Genetics, General Electric and HHS. The company has 105 employees. Its chief executive, as recorded, is Kathy Ordonez. The company was acqui-hired. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Pan Cancer. Its legal entity is RAINDANCE TECHNOLOGIES, INC. 401K PLAN. Its competitors include GRAIL, PacBio and Color; 3 of its 3 listed competitors have raised funding.
Company details
RainDance was founded in 2004 in Billerica, United States, within the biotechnology sector. Nucleic acid detection and quantification systems are developed, manufactured, and sold based on proprietary single-molecule PCR technology, which processes reactions in millions of uniform 5-picoliter droplets for enhanced sensitivity and specificity compared to traditional methods. A next-generation sequencing target enrichment system is also offered, including instrumentation and pre-validated gene panels.
- Headquarters Billerica, United States
- Employees 105
- Stage Acquired
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website raindancetech.com
- Social LinkedIn X
- Acquired by Bio Rad (Jan 2017)
- Legal Name Raindance Technologies, Inc. 401K Plan
- Total Equity Funding$111.66M (USD)
in 17 rounds
- Latest Funding Round$16.5M (USD), Series E
Feb 2014
- InvestorsMyriad Genetics
& 10 more
- Employee Count105
- Acquired byBio Rad
(Jan 2017)
Funding Insights of RainDance
RainDance has successfully raised a total of $111.66M across 17 strategic funding rounds. The most recent funding activity was a Series E round of $16.5 million completed in February 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $111.66M
- Total Rounds 17
- Last Round Series E — $16.5M
- First Round $747,984
(Jul 2006)
- Investors Count 10
Latest 10 of 17 funding rounds of RainDance with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2014 | $16.5M | Series E | – | – | |
| Sep 2013 | $35M | Debt – Conventional | – | – | |
| Apr 2013 | $20M | Series E | – | Myriad Genetics | |
| Jan 2011 | $37.5M | Series D | – | Quaker Partners | |
| Jul 2010 | Grant | – | – | ||
| Jun 2010 | $96,738 | Grant | – | – | |
| Mar 2010 | $200,035 | Grant | – | – | |
| Mar 2010 | $200,035 | Grant | – | – | |
| Feb 2010 | $193,520 | Grant | – | – | |
| Feb 2010 | $193,520 | Grant | – | – |
11 investors in total: 11 institutional.
Investors in RainDance
RainDance has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Myriad Genetics, General Electric and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Northgate Capital is engaged in venture capital and private equity investments. | 2000 | northgate.com | San Francisco, United States | |
CRG is recognized as a premier healthcare investment partner. | crglp.com | Houston, United States | ||
Venture capital investments are managed in technology and healthcare sectors by this firm. | mdv.com | |||
Early stage venture capital firm investing in the US | alloyventures.com | Palo Alto, United States | ||
Sectoral Asset Management is focused on global healthcare investment. | 2000 | sectoral.com | Montreal, Canada | |
Diversified operations are conducted across multiple industries worldwide. | 1892 | ge.com | United States | |
| quakerbio.com | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
| pequotcap.com | ||||
Molecular diagnostics and personalized medicine for cancer are developed. | 1991 | myriad.com | United States |
Investor details for RainDance
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of RainDance
1 people are tracked at RainDance (1 in leadership); the tracked headcount is 105.
| Name | Role | Group |
|---|---|---|
Kathy Ordonez | CEO | Leadership |
Complete people profiles for RainDance
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of RainDance
4 dated milestones of RainDance across 13 years, from founding to its latest funding, stage changes and deals.
- Founded RainDance is founded.
- Funding First funding round of $748K.
- Funding Latest funding round, Series E, of $16.5M.
- Exit Acquired by Bio Rad.
Competitors of RainDance
RainDance has 3 listed competitors in our database, 3 of them funded. They include GRAIL, PacBio and Color.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| grail.com | 2016 | Menlo Park, United States | $2B | 491 | Circulating tumor DNA is screened for early cancer detection. | |
| pacb.com | 2004 | Menlo Park, United States | $395M | 649 | Instrument systems and software for single-molecule real-time sequencing are developed. | |
| color.com | 2013 | Burlingame, United States | $491.44M | 687 | Cancer care is delivered through a virtual clinic by Color. |
Detailed competitors of RainDance
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of RainDance
Websites that share an audience with RainDance (raindancetech.com).
Websites whose visitors overlap most with RainDance. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| fluidigm.com | 100% | 1.1K | #14,860,207 | View details | |
| illumina.com | 99% | 672.7K | #61,793 | View details | |
| neb.com | 60% | 749.5K | #69,042 | View details | |
| perkinelmer.com | 48% | 164.5K | #258,286 | View details | |
| sepax-tech.com | 45% | 2K | #8,305,742 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for RainDance
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as RainDance (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RainDance
RainDance was founded in 2004 and raised its 1st funding round 2 years after it was founded.
RainDance is headquartered in Billerica, United States. It is registered at Billerica, Massachusetts, United States.
Kathy Ordonez is the CEO of RainDance, as recorded in our data.
RainDance is a funded company, having raised a total of $111.66M across 17 funding rounds to date. The company's 1st funding round was a Grant of $193.52K, raised on Jul 2006.
RainDance has 105 employees.
RainDance was founded in 2004 in Billerica, United States, within the biotechnology sector. Nucleic acid detection and quantification systems are developed, manufactured, and sold based on proprietary single-molecule PCR technology, which processes reactions in millions of uniform 5-picoliter droplets for enhanced sensitivity and specificity compared to traditional methods. A next-generation sequencing target enrichment system is also offered, including instrumentation and pre-validated gene panels.
RainDance has 11 investors. Key investors include Myriad Genetics, General Electric, HHS, Bio Rad, and Northgate Capital.
RainDance operates through Raindance Technologies, Inc. 401K Plan.
Yes. RainDance was acquired by Bio Rad in January 2017.